Darja Fer cej-Temeljotov

Title: Darja Fer cej-Temeljotov: Innovator in Pharmaceutical Chemistry

Introduction

Darja Fer cej-Temeljotov is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel inclusion complexes for medical applications. His work focuses on improving the efficacy of medications used in the treatment of infectious diseases.

Latest Patents

Darja holds a patent for "Inclusion complexes of clavulanic acid and of alkali salts thereof." This patent describes a new process for preparing alkali clavulanate from an aqueous solution of crude clavulanic acid. The process involves extracting clavulanic acid with an ethyl acetate solution of a hydrophobic β-cyclodextrin derivative. The resulting inclusion complexes are isolated, purified, and converted into the desired alkali clavulanate. This innovation is crucial for creating effective pharmaceutical formulations in combination with amoxicillin trihydrate.

Career Highlights

Darja is currently employed at Lek, Tovarna Farmacevtskih in Kemicnih, a leading pharmaceutical company in Slovenia. His work at Lek has allowed him to focus on the development of new drug formulations that enhance therapeutic outcomes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of pharmaceutical innovation.

Collaborations

Throughout his career, Darja has collaborated with talented professionals in the field. Notable coworkers include Janko Zmitek and Katarina Verhnjak, who have contributed to various projects and research initiatives. Their combined expertise has fostered a collaborative environment that promotes innovation and advancement in pharmaceutical sciences.

Conclusion

Darja Fer cej-Temeljotov is a pioneering inventor whose work in pharmaceutical chemistry has the potential to significantly impact the treatment of infectious diseases. His innovative approaches to drug formulation and collaboration with skilled colleagues highlight his commitment to advancing medical science.